Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced that its subsidiary, Guangzhou Pharmaceuticals Co., Ltd. (GP Corp.), has received approval for the public transfer and quotation of its shares on the National Equities Exchange and Quotations (NEEQ). This move allows GP Corp. to be governed as a non-listed public company while remaining a non-wholly owned subsidiary of Guangzhou Baiyunshan. The quotation on NEEQ will not significantly impact the financial position or operations of the parent company, maintaining its status as an independently listed entity.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company established in the People’s Republic of China, operating in the pharmaceutical industry. The company is primarily involved in the production and distribution of pharmaceutical products, focusing on the Chinese market.
YTD Price Performance: 2.18%
Average Trading Volume: 30,548
Technical Sentiment Signal: Strong Buy
Current Market Cap: $5.46B
See more data about 0874 stock on TipRanks’ Stock Analysis page.